Antimicrobial Resistance Poses Growing Threat Across Europe

OPA WIRE, Nov 7 (OPA) — Antimicrobial resistance (AMR) matches the combined health toll of influenza, tuberculosis, and HIV/AIDS within the European Union. Bacterial pathogens increasingly evade standard pharmaceuticals, leaving clinicians with severely limited therapeutic options for infected patients.

"Antibiotic resistance is when bugs can't get treated with the medicines anymore that we usually use to treat them," said Fiona Walsh, a professor at Maynooth University in Ireland. Multidrug-resistant infections frequently force physicians to administer combination therapies, though these interventions occasionally fail entirely, resulting in patient mortality.

Global projections indicate that bacterial AMR could directly cause 39 million deaths worldwide between 2025 and 2050, according to data published in The Lancet. Primary drivers of this crisis include human antibiotic overuse, agricultural animal usage, inadequate sanitation, and environmental pollution that facilitates gene transfer.

Mitigating the threat requires a multifaceted One Health framework linking human, animal, and environmental management. Researchers emphasize that expanding vaccine coverage, improving wastewater treatment, and preserving natural human microbiome defenses remain essential to reducing overall antibiotic dependency.